Calidi Biotherapeutics, Inc. (CLDI)

EBITDA Margin

-51371.11%

TTM · Period ending:

CLDI logo

CLDI EBITDA Margin

Latest reported-51371.11%
CLDI TTM EBITDA Margin (-1898.73% → -51371.11%)
High-resolution chart · PNG

CLDI ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Calidi Biotherapeutics, Inc. EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-51,371.1111%
-3,802.4444%
-2,899.6198%
-1,898.7309%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.